HIV: traditional small molecules or the new biologics?

HIV: traditional small molecules or the new biologics?
- Since it became clear that monoclonal antibodies and recombinant proteins will revolutionise the pharmaceutical industry, the interests of small, medium and large pharmaceutical companies in personalised medicine has grown rapidly. Biologics are set to dominate oncology and auto-immune diseases, ...